Key Points
TerrAscend ordered to repay $8.4M erroneous tax refund under IRC Section 280E.
Section 280E prohibits cannabis businesses from deducting ordinary business expenses, forcing tax on gross revenue.
IRS enforcement signals tightening compliance standards across cannabis industry.
Cannabis investors must factor tax liabilities and audit risk into investment decisions.
The U.S. Department of Justice has ordered TerrAscend USA Inc. to repay an $8.4 million tax refund it received for the 2020 tax year, plus accrued interest. The federal government argues the refund was erroneous under IRC Section 280E, a statute that prohibits tax deductions for businesses involved in cannabis sales. This enforcement action marks a significant moment for cannabis industry compliance, as the IRS tightens scrutiny on multi-state operators (MSOs) seeking tax relief. The ruling underscores how federal cannabis prohibition continues to create tax barriers for legitimate businesses operating in legal state markets.
What Is IRC Section 280E and Why It Matters
IRC Section 280E prevents businesses trafficking in controlled substances from deducting ordinary business expenses. This rule applies to cannabis companies even in states where marijuana is legal. The statute creates a unique tax burden: cannabis businesses cannot deduct costs like rent, payroll, or utilities, forcing them to pay federal income tax on gross revenue rather than net profit.
For TerrAscend, the IRS claims the $8.4 million refund should never have been issued because the company failed to comply with Section 280E rules. The government filed suit in U.S. District Court for the District of New Jersey to recover the funds. This enforcement action signals the IRS is actively auditing cannabis companies and reversing improper refunds.
TerrAscend’s Tax Refund Dispute and Legal Implications
TerrAscend received the $8.4 million refund for its 2020 tax year, but the Department of Justice now claims it was granted in error. The government argues the refund violated Section 280E restrictions. The company must repay the full amount plus interest accrued since the refund was issued.
This case sets a precedent for how federal courts will handle cannabis tax disputes. If TerrAscend loses, other MSOs facing similar audits may face comparable demands. The ruling also highlights the gap between state-legal cannabis operations and federal tax law, creating compliance risks for the entire industry.
Broader Impact on Cannabis Industry Tax Compliance
The TerrAscend case reflects growing IRS enforcement against cannabis businesses claiming improper deductions. Federal authorities are scrutinizing erroneous refunds issued to cannabis companies. Many MSOs have faced similar audits as the IRS tightens compliance standards.
Cannabis operators must now assume Section 280E will be strictly enforced, limiting their ability to reduce taxable income through standard business deductions. This tax burden makes profitability harder for cannabis companies compared to other industries. Investors should monitor how this enforcement trend affects MSO earnings and cash flow going forward.
What Investors Should Know About Cannabis Tax Risk
Cannabis companies operate under unique federal tax constraints that create structural disadvantages. Section 280E forces cannabis businesses to pay federal income tax on gross revenue, not net profit, significantly reducing after-tax returns. The TerrAscend case demonstrates the IRS will aggressively recover improper refunds, adding legal and financial risk to MSO operations.
Investors holding cannabis stocks should factor in potential tax liabilities and audit exposure. Companies with aggressive tax strategies face higher risk of IRS enforcement. Transparent tax compliance and conservative deduction practices are now critical for cannabis operators seeking to avoid costly disputes and maintain investor confidence.
Final Thoughts
TerrAscend’s $8.4 million tax refund dispute signals intensifying IRS enforcement against cannabis companies claiming improper deductions under Section 280E. The ruling reinforces that federal cannabis prohibition creates lasting tax barriers for state-legal operators, forcing them to pay tax on gross revenue rather than net profit. Investors should view this case as a warning: cannabis companies with aggressive tax strategies face significant audit and repayment risk, making tax compliance and transparency essential for long-term viability in the industry.
FAQs
Section 280E prohibits tax deductions for businesses trafficking in controlled substances, including cannabis. Cannabis companies must pay federal income tax on gross revenue, not net profit, creating a significant tax burden compared to other industries.
The IRS claims the refund was erroneous because TerrAscend violated Section 280E rules. The Department of Justice filed suit to recover the funds plus accrued interest, arguing the company should never have received the refund in the first place.
The case sets a precedent for IRS enforcement against cannabis MSOs. Other companies facing similar audits may face comparable demands to repay improper refunds, signaling stricter federal compliance standards across the industry.
Investors should monitor cannabis companies’ tax compliance practices and audit exposure. Companies with transparent, conservative tax strategies face lower risk. Tax liabilities and potential refund demands should factor into investment decisions and earnings forecasts.
Disclaimer:
The content shared by Meyka AI PTY LTD is solely for research and informational purposes. Meyka is not a financial advisory service, and the information provided should not be considered investment or trading advice.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask Meyka Analyst about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)